You are here

Constellation Pharmaceuticals to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 22, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar Raythatha, CEO, will present at the SVB Leerink Global Healthcare Conference in New York at 9:00 AM EST on Friday, March 1, and at the Cowen and Company Health Care Conference in Boston at 11:20 AM EDT on Monday, March 11.  Live audio webcasts of these presentations and archives for replay will be available on the Investor Relations section of Constellation’s website at  The audio webcast replays will be available for 90 days following the live presentation.
Friday, February 22, 2019 - 13:24